Protein is highly satiating, meaning it helps you feel full for longer
While the medication itself does not require tapering from a pharmacological standpoint, the clinical context surrounding discontinuationparticularly the management of underlying conditions like diabetes or obesitydemands careful planning and medical supervision to ensure patient safety and optimize long-term health outcomes
The key principle is managing the underlying condition, not tapering the drug
To check coverage, patients visit: where they will enter their name, insurance info, and some relevant eligibility information
It is a transition process, designed to move from full treatment to no medication while allowing appetite and eating patterns to adjust more gradually
Long-term safety data extends to four or more years for semaglutide and continues to accumulate for tirzepatide